NGL Fine-Chem Ltd Sustainability Reports

NGL Fine-Chem Limited manufactures active pharmaceutical ingredients (APIs) and intermediates for both veterinary and human health markets. The company specializes in complex multi-step organic synthesis to deliver generic pharmaceuticals globally.

Sector: Manufacturing

Country: India

Exchange: Bombay Stock Exchange

LEI: 335800X5TUU2OAV19X07

FIGI: BBG001S7KL75

14 reports from 2016 to 2026

• NGL Fine-Chem Ltd 2026 Annual Report
• NGL Fine-Chem Ltd 2026 Business Responsibility and Sustainability Report
• NGL Fine-Chem Ltd 2025 Annual Report
• NGL Fine-Chem Ltd 2024 Business Responsibility and Sustainability Report
• NGL Fine-Chem Ltd 2024 Annual Report